Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/13/2005 | US20050229264 Recombinant gelatins |
10/13/2005 | US20050228170 B7-like molecules and uses thereof |
10/13/2005 | US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof |
10/13/2005 | US20050228026 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent |
10/13/2005 | US20050228018 Chemical compounds |
10/13/2005 | US20050228004 administering drugs such as 3-[2-(Cyclopentylamino)-4-pyrimidinyl]-2-(4-fluorophenyl)imidazo[1,2-a]pyridin-8-amine, for therapy of viral diseases caused by DNA viruses |
10/13/2005 | US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment |
10/13/2005 | US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants |
10/13/2005 | US20050227990 Aminoalkoxy-functional chalcones |
10/13/2005 | US20050227986 Vanilloid receptor ligands and their use in treatments |
10/13/2005 | US20050227942 Use of Asialo-Gm1 (Agm1,) and/or GM gangliosides, and substances which simulate carbohydrate moiety of these gangliosides with regard to binding to anti-AGM1 antibodies and/or anti-GM1 antibodies, for the preparation of an agent for binding or blocking anti-AGM1 antibodies and/or anti-GM1 antibodies |
10/13/2005 | US20050227910 Local regional chemotherapy and radiotherapy using in situ hydrogel |
10/13/2005 | US20050227354 Using fibronectin nutrient broth to propagate cytotoxic lymphocyte with enhanced interleukin-2 receptor expression profiles; immunotherapy; antitumor agents |
10/13/2005 | US20050227285 Control of gene expression in eukaryotic cells |
10/13/2005 | US20050227280 Proteases |
10/13/2005 | US20050227277 Apoptosis proteins |
10/13/2005 | US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications |
10/13/2005 | US20050226897 Method of protecting against coccidiosis |
10/13/2005 | US20050226884 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy |
10/13/2005 | US20050226874 Point mutations; immunology |
10/13/2005 | US20050226851 Lysin-deficient bacteriophages having reduced immunogenicity |
10/13/2005 | US20050223628 Fuel additive |
10/13/2005 | CA2562947A1 Antibacterial composition comprising cheese and low ph |
10/13/2005 | CA2561896A1 Antiviral agents |
10/13/2005 | CA2561732A1 Antibody drug |
10/13/2005 | CA2561530A1 Therapeutic or prophylactic agent for arthritis |
10/13/2005 | CA2499113A1 Medicinal product |
10/12/2005 | EP1584628A2 Viral protein |
10/12/2005 | EP1584623A1 A group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
10/12/2005 | EP1583967A2 Method for inhibiting the replication of herpes viruses |
10/12/2005 | EP1583773A1 Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
10/12/2005 | EP1583744A2 Substituted benzylamine derivatives and methods of use |
10/12/2005 | EP1583558A2 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
10/12/2005 | EP1583553A2 Therapeutic use of modulators of notch |
10/12/2005 | EP1583542A1 Compositions and methods for combination antiviral therapy |
10/12/2005 | EP1419174A4 Process for preparing glycopeptide derivatives |
10/12/2005 | EP1313749B1 Process for preparation of anhydrous azithromycin |
10/12/2005 | EP1242096B1 Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium |
10/12/2005 | EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists |
10/12/2005 | EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha |
10/12/2005 | EP1140848B1 Phenethyl-5-bromopyridylthiourea (pbt) derivatives exhibiting spermicidal activity |
10/12/2005 | EP1140033B1 Improved controlled release compositions |
10/12/2005 | EP1140027B1 Dosage forms comprising porous particles |
10/12/2005 | EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives |
10/12/2005 | CN1681919A Chicken astrovirus type 2 |
10/12/2005 | CN1681832A Lincomycin derivatives possessing antibacterial activity |
10/12/2005 | CN1681818A Azaindole kinase inhibitors |
10/12/2005 | CN1681814A Preparation of 1H-imidazo [4, 5-C] quinolin-4-amines via 1H-imidazo [4, 5-C] quinolin-4-phthalimide intermediates |
10/12/2005 | CN1681811A Azolidinone-vinyl fused-benzene derivatives |
10/12/2005 | CN1681801A Quinolylpropylpiperidine derivatives and their use as anti-microorgans agent |
10/12/2005 | CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
10/12/2005 | CN1681774A Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2, 6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile |
10/12/2005 | CN1681770A Amino-propanol derivatives |
10/12/2005 | CN1681534A Drug absorbability improving agents |
10/12/2005 | CN1681531A Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
10/12/2005 | CN1681522A Megasphaera elsdenii strain and its uses |
10/12/2005 | CN1681520A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
10/12/2005 | CN1681519A Hepatitis c virus inhibitor comprising alpha-glycosylceramide as the active ingredient |
10/12/2005 | CN1681518A Combination therapies with L-FMAU for the treatment of hepatitis b virus infection |
10/12/2005 | CN1681508A Novel inhibitors of kinases |
10/12/2005 | CN1681494A 4-(3, 5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of I.A. HIV |
10/12/2005 | CN1680592A Diagnostic assay |
10/12/2005 | CN1680568A Microbiological coverting product of curcumenol, use and preparation thereof |
10/12/2005 | CN1680566A Pseudomycin production by pseudomonas syringae |
10/12/2005 | CN1680553A Penicillium marneffei 40S ribosomal protein S28, its coding sequence and use |
10/12/2005 | CN1680549A Dendritic cell obtained by antigen pulsing |
10/12/2005 | CN1680451A Immune responses against HPV antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
10/12/2005 | CN1680448A Macrogol-interferon, preparation and use thereof |
10/12/2005 | CN1680447A Neutralizing high affinity human monoclonal antibodies specific to respiratory syncytial virus f-protein |
10/12/2005 | CN1680445A Antithemolytic streptococcus, staphylococcus and candida albicans lgG antibody and preparation thereof |
10/12/2005 | CN1680434A Streptococcus pneumoniae antigens |
10/12/2005 | CN1680432A Viral protein |
10/12/2005 | CN1680420A Keto-lactones compound, its purposes, preparation method and pharmaceutical compositio |
10/12/2005 | CN1680419A Keto-lactones compound, its purposes, preparation method and pharmaceutical compositio |
10/12/2005 | CN1680418A Keto-lactones compound, its purposes, preparation method and pharmaceutical composition |
10/12/2005 | CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
10/12/2005 | CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels |
10/12/2005 | CN1680333A Anti-virus pyrazole derivatives |
10/12/2005 | CN1680252A C60 trans-succinate with biologic activity and its synthesis |
10/12/2005 | CN1679981A Medicine composition for treating beriberi |
10/12/2005 | CN1679963A Coupling agent of CB and specific immune globulin IgG and use thereof |
10/12/2005 | CN1679938A Pharmaceutical compositions |
10/12/2005 | CN1679932A Ordered molecular presentation of antigens, method of preparation and use |
10/12/2005 | CN1679931A Canine distemper virus separated in korea and recombined vaccine therefrom |
10/12/2005 | CN1679929A Streptococcal c5a peptidase vaccine |
10/12/2005 | CN1679926A Use of human lysozyme in preparing anti-virus medicines for influenza |
10/12/2005 | CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist |
10/12/2005 | CN1679915A Peptide antagonists of zonulin and methods for use of the same |
10/12/2005 | CN1679901A Compound preparation of Jianganling for liver and its making method |
10/12/2005 | CN1679893A Medicine for treating AIDS and preparation thereof |
10/12/2005 | CN1679888A Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof |
10/12/2005 | CN1679887A Chinese medicine composition for treating hepatitis |
10/12/2005 | CN1679872A Blackberrylily rhizome antiviral injection, preparation and venous medicine feeding blackberrylily rhizome antiviral injection thereof |
10/12/2005 | CN1679865A Extract of common leafflower and medicinal composition with it as active component and use thereof |
10/12/2005 | CN1679852A Pigment for preventing and treating foot-mouth disease of livestock and production thereof |
10/12/2005 | CN1679848A Compound Chinese medicine material for sterilizing AIDS virus and influenza virus, production thereof |
10/12/2005 | CN1679842A Oldenlandia and powder injection and preparation thereof |
10/12/2005 | CN1679816A Freeze-dried powder injection of Tianjihuang and its making method |
10/12/2005 | CN1679812A Quick acting xingjiling preparation for sextual diseases |
10/12/2005 | CN1679809A Chinese medicine composition for treating heaves and hepatitis of fowl and livestock |